CD36, CD36 molecule, 948
N. diseases: 304; N. variants: 34
Source: BEFREE ×
| Disease | Score gda | Association Type | Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.060 | Biomarker | phenotype | BEFREE | Hence, promotion of metastasis by pancreatic tumor microvesicles is associated with CD36-regulated immune cell invasion and extravasation of microvesicles and persistent infiltration of specific tissue macrophages by microvesicle cargo.-Pfeiler, S., Thakur, M., Grünauer, P., Megens, R. T. A., Joshi, U., Coletti, R., Samara, V., Müller-Stoy, G., Ishikawa-Ankerhold, H., Stark, K., Klingl, A., Fröhlich, T., Arnold, G. J., Wörmann, S., Bruns, C. J., Algül, H., Weber, C., Massberg, S., Engelmann, B. CD36-triggered cell invasion and persistent tissue colonization by tumor microvesicles during metastasis. | 30207797 | 2019 | ||||
|
0.060 | Biomarker | phenotype | BEFREE | Importantly, inhibition of CD36 reduced lipid droplet accumulation and attenuated the migration and invasion of the breast cancer cells. | 31847105 | 2019 | ||||
|
0.060 | Biomarker | phenotype | BEFREE | Wound-healing assays, migration assays, and invasion assays were performed and peritoneal implants into nude mice were done to assess the biological effects of PA and CD36. | 30717785 | 2019 | ||||
|
0.060 | Biomarker | phenotype | BEFREE | In vitro invasion and in vivo metastasis assays were also used to evaluate the role of CD36 in cervical cancer metastasis. | 31655604 | 2019 | ||||
|
0.060 | AlteredExpression | phenotype | BEFREE | Overexpression of CD36 partially restored the proliferation and invasion capacity inhibited by miR-1254. | 31401948 | 2019 | ||||
|
0.060 | Biomarker | phenotype | BEFREE | Nobiletin inhibited CD36-dependent breast cancer cell migration and invasion as well as CD36-mediated tumor sphere formation. | 29914089 | 2018 |